The University of Chicago Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Jubao Duan and Alan Sanders.
Connection Strength

6.080
  1. Female iPSC X chromosome inactivation erosion and its transcriptomic effects during CRISPR gene editing and neural differentiation. Stem Cell Reports. 2026 Oct 15; 103120.
    View in: PubMed
    Score: 0.248
  2. Single-cell multiomics of neuron activation reveals context-specific genetics of brain disorders. Science. 2026 Jun 25; 392(6805):eadw3949.
    View in: PubMed
    Score: 0.243
  3. Female iPSC X-chromosome inactivation (XCI) erosion and its transcriptomic effects during CRISPR gene editing and neural differentiation. bioRxiv. 2026 Mar 01.
    View in: PubMed
    Score: 0.238
  4. PICALM Alzheimer's risk allele causes aberrant lipid droplets in microglia. Nature. 2025 10; 646(8087):1178-1186.
    View in: PubMed
    Score: 0.230
  5. Alzheimer's disease protective allele of Clusterin modulates neuronal excitability through lipid-droplet-mediated neuron-glia communication. Mol Neurodegener. 2025 05 03; 20(1):51.
    View in: PubMed
    Score: 0.225
  6. Single-cell multiomics of neuronal activation reveals context-dependent genetic control of brain disorders. bioRxiv. 2025 Feb 17.
    View in: PubMed
    Score: 0.222
  7. Scaled and efficient derivation of loss-of-function alleles in risk genes for neurodevelopmental and psychiatric disorders in human iPSCs. Stem Cell Reports. 2024 10 08; 19(10):1489-1504.
    View in: PubMed
    Score: 0.215
  8. Alzheimer's disease protective allele of Clusterin modulates neuronal excitability through lipid-droplet-mediated neuron-glia communication. medRxiv. 2024 Aug 15.
    View in: PubMed
    Score: 0.214
  9. Alzheimer's disease risk allele of PICALM causes detrimental lipid droplets in microglia. Res Sq. 2024 May 24.
    View in: PubMed
    Score: 0.211
  10. Scaled and Efficient Derivation of Loss of Function Alleles in Risk Genes for Neurodevelopmental and Psychiatric Disorders in Human iPSC. bioRxiv. 2024 Mar 19.
    View in: PubMed
    Score: 0.208
  11. Brain Lipids and Lipid Droplet Dysregulation in Alzheimer's Disease and Neuropsychiatric Disorders. Complex Psychiatry. 2023 Jan-Dec; 9(1-4):154-171.
    View in: PubMed
    Score: 0.203
  12. Multiple genes in a single GWAS risk locus synergistically mediate aberrant synaptic development and function in human neurons. Cell Genom. 2023 Sep 13; 3(9):100399.
    View in: PubMed
    Score: 0.200
  13. Modeling PTSD neuronal stress responses in a dish. Nat Neurosci. 2022 11; 25(11):1402-1404.
    View in: PubMed
    Score: 0.189
  14. Loss of function of OTUD7A in the schizophrenia- associated 15q13.3 deletion impairs synapse development and function in human neurons. Am J Hum Genet. 2022 08 04; 109(8):1500-1519.
    View in: PubMed
    Score: 0.186
  15. Cell type-specific and cross-population polygenic risk score analyses of MIR137 gene pathway in schizophrenia. iScience. 2021 Jul 23; 24(7):102785.
    View in: PubMed
    Score: 0.172
  16. Sex-specific nicotine sensitization and imprinting of self-administration in rats inform GWAS findings on human addiction phenotypes. Neuropsychopharmacology. 2021 09; 46(10):1746-1756.
    View in: PubMed
    Score: 0.171
  17. Allele-specific open chromatin in human iPSC neurons elucidates functional disease variants. Science. 2020 07 31; 369(6503):561-565.
    View in: PubMed
    Score: 0.162
  18. From Schizophrenia Genetics to Disease Biology: Harnessing New Concepts and Technologies. J Psychiatr Brain Sci. 2019; 4.
    View in: PubMed
    Score: 0.152
  19. The Genetic Relevance of Human Induced Pluripotent Stem Cell-Derived Microglia to Alzheimer's Disease and Major Neuropsychiatric Disorders. Mol Neuropsychiatry. 2020 Apr; 5(Suppl 1):85-96.
    View in: PubMed
    Score: 0.151
  20. Transcriptomic signatures of schizophrenia revealed by dopamine perturbation in an ex vivo model. Transl Psychiatry. 2018 08 16; 8(1):158.
    View in: PubMed
    Score: 0.141
  21. Open chromatin dynamics reveals stage-specific transcriptional networks in hiPSC-based neurodevelopmental model. Stem Cell Res. 2018 05; 29:88-98.
    View in: PubMed
    Score: 0.137
  22. Genome-Wide Association Study of Male Sexual Orientation. Sci Rep. 2017 12 07; 7(1):16950.
    View in: PubMed
    Score: 0.135
  23. Open Chromatin Profiling in hiPSC-Derived Neurons Prioritizes Functional Noncoding Psychiatric Risk Variants and Highlights Neurodevelopmental Loci. Cell Stem Cell. 2017 09 07; 21(3):305-318.e8.
    View in: PubMed
    Score: 0.132
  24. Transcriptome outlier analysis implicates schizophrenia susceptibility genes and enriches putatively functional rare genetic variants. Hum Mol Genet. 2015 Aug 15; 24(16):4674-85.
    View in: PubMed
    Score: 0.113
  25. A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder. Am J Hum Genet. 2014 Dec 04; 95(6):744-53.
    View in: PubMed
    Score: 0.109
  26. Transcriptome study of differential expression in schizophrenia. Hum Mol Genet. 2013 Dec 15; 22(24):5001-14.
    View in: PubMed
    Score: 0.099
  27. Genome-wide survey of interindividual differences of RNA stability in human lymphoblastoid cell lines. Sci Rep. 2013; 3:1318.
    View in: PubMed
    Score: 0.096
  28. The Internet-based MGS2 control sample: self report of mental illness. Am J Psychiatry. 2010 Jul; 167(7):854-65.
    View in: PubMed
    Score: 0.080
  29. Genome-wide approaches to schizophrenia. Brain Res Bull. 2010 Sep 30; 83(3-4):93-102.
    View in: PubMed
    Score: 0.079
  30. The role of genetics in the etiology of schizophrenia. Psychiatr Clin North Am. 2010 Mar; 33(1):35-66.
    View in: PubMed
    Score: 0.078
  31. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry. 2008 Apr; 165(4):497-506.
    View in: PubMed
    Score: 0.068
  32. DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene. Hum Hered. 2007; 64(2):97-106.
    View in: PubMed
    Score: 0.065
  33. Neuregulin 1 (NRG1 ) and schizophrenia: analysis of a US family sample and the evidence in the balance. Psychol Med. 2005 Nov; 35(11):1599-610.
    View in: PubMed
    Score: 0.058
  34. Lipid trajectories improve risk models for Alzheimer's disease and mild cognitive impairment. J Lipid Res. 2025 01; 66(1):100714.
    View in: PubMed
    Score: 0.054
  35. Lipid Trajectories Improve Risk Models for Alzheimer's Disease and Mild Cognitive Impairment. medRxiv. 2024 Sep 28.
    View in: PubMed
    Score: 0.054
  36. Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. Am J Hum Genet. 2004 Oct; 75(4):624-38.
    View in: PubMed
    Score: 0.054
  37. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet. 2003 Feb 01; 12(3):205-16.
    View in: PubMed
    Score: 0.048
  38. Excitatory Dysfunction Drives Network and Calcium Handling Deficits in 16p11.2 Duplication Schizophrenia Induced Pluripotent Stem Cell-Derived Neurons. Biol Psychiatry. 2023 07 15; 94(2):153-163.
    View in: PubMed
    Score: 0.047
  39. DNA variation and psychopharmacology of the human serotonin receptor 1B (HTR1B) gene. Pharmacogenomics. 2002 Nov; 3(6):745-62.
    View in: PubMed
    Score: 0.047
  40. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022 04; 604(7906):502-508.
    View in: PubMed
    Score: 0.045
  41. Dopamine perturbation of gene co-expression networks reveals differential response in schizophrenia for translational machinery. Transl Psychiatry. 2018 12 13; 8(1):278.
    View in: PubMed
    Score: 0.036
  42. Analysis of shared heritability in common disorders of the brain. Science. 2018 06 22; 360(6395).
    View in: PubMed
    Score: 0.035
  43. Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data. PLoS Genet. 2016 Dec; 12(12):e1006493.
    View in: PubMed
    Score: 0.032
  44. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet. 2017 01; 49(1):27-35.
    View in: PubMed
    Score: 0.031
  45. Parental Origin of Interstitial Duplications at 15q11.2-q13.3 in Schizophrenia and Neurodevelopmental Disorders. PLoS Genet. 2016 05; 12(5):e1005993.
    View in: PubMed
    Score: 0.030
  46. New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. Int J Epidemiol. 2015 Oct; 44(5):1706-21.
    View in: PubMed
    Score: 0.029
  47. The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study. PLoS Genet. 2015 Oct; 11(10):e1005378.
    View in: PubMed
    Score: 0.029
  48. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013 Oct; 45(10):1150-9.
    View in: PubMed
    Score: 0.025
  49. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013 Sep; 45(9):984-94.
    View in: PubMed
    Score: 0.025
  50. Reciprocal duplication of the Williams-Beuren syndrome deletion on chromosome 7q11.23 is associated with schizophrenia. Biol Psychiatry. 2014 Mar 01; 75(5):371-7.
    View in: PubMed
    Score: 0.025
  51. Genome-wide association study of clinical dimensions of schizophrenia: polygenic effect on disorganized symptoms. Am J Psychiatry. 2012 Dec; 169(12):1309-17.
    View in: PubMed
    Score: 0.024
  52. Genome-wide association study of multiplex schizophrenia pedigrees. Am J Psychiatry. 2012 Sep; 169(9):963-73.
    View in: PubMed
    Score: 0.023
  53. Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. Arch Gen Psychiatry. 2012 Aug; 69(8):854-60.
    View in: PubMed
    Score: 0.023
  54. Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25. Genet Epidemiol. 2012 May; 36(4):340-51.
    View in: PubMed
    Score: 0.023
  55. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry. 2011 Mar; 168(3):302-16.
    View in: PubMed
    Score: 0.021
  56. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010 Nov; 42(11):937-48.
    View in: PubMed
    Score: 0.020
  57. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature. 2010 Oct 14; 467(7317):832-8.
    View in: PubMed
    Score: 0.020
  58. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature. 2009 Aug 06; 460(7256):753-7.
    View in: PubMed
    Score: 0.019
  59. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet. 2008 Sep; 40(9):1053-5.
    View in: PubMed
    Score: 0.018
  60. Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet. 2006 Feb; 78(2):315-33.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.